Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.
about
Fat content, fatty acid pattern and iron content in livers of turkeys with hepatic lipidosis.Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway.Stable isotope-based flux studies in nonalcoholic fatty liver disease.Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.Linarin Enriched Extract Attenuates Liver Injury and Inflammation Induced by High-Fat High-Cholesterol Diet in Rats.Melatonin application in targeting oxidative-induced liver injuries: A review.G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study.Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats.Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis.Non-Alcoholic Fatty Liver Disease.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.Caspases in metabolic disease and their therapeutic potential.Liraglutide reduces hepatic glucolipotoxicity‑induced liver cell apoptosis through NRF2 signaling in Zucker diabetic fatty rats.Cholesterol-lowering effects and potential mechanisms of chitooligosaccharide capsules in hyperlipidemic rats.Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B.Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.Endoplasmic Reticulum Stress in Metabolic Disorders.Apoptosis and non-alcoholic fatty liver diseases.New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisHepatoprotective and Antioxidant Activities of Oil from Baru Almonds ( Vog.) in a Preclinical Model of Lipotoxicity and DyslipidemiaDiabetes and Alzheimer's Disease: Mechanisms and Nutritional AspectsPathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
P2860
Q33743274-B37BF8CC-230A-47A4-A74C-8DC750DAEAC0Q33855157-BDFDAD91-ACF1-436D-A9D7-1FE8AF2C3AA2Q37454201-4AB23A9F-5017-40B4-9217-C06DA94AEB03Q38655651-206CDDCB-ECFB-4B64-B120-27DCD52D96B9Q38794320-5B8ACDD8-37A9-4D07-84F8-6FB672602A45Q40979699-D4342814-B8ED-4419-ACC4-3E77A8011D90Q46288090-EA22ECAC-4299-4186-9FB4-9299D8BFCED9Q47311472-B6500FEB-8EB7-489D-87CB-65FFD1036DA6Q47871089-11C30282-A7E1-4F18-B295-CFFC65E269C1Q48144949-2C18DE6D-A7D3-48F1-ABD6-81F51B784D7AQ48184818-2029B028-E95A-4865-BD21-442521CBB47AQ49331156-DD117385-6013-4F20-8E47-50B8346786D7Q50957769-4E1E53D9-5667-43BE-A769-B8F8ED5358D4Q51761242-78AF99A1-18B2-43A4-B992-DA6DCC867A71Q53685192-18D869F7-B1F7-40FD-AFA1-D56B2EE1226CQ54946966-FEB11184-5F8C-4B46-89A3-DEF27D2F843BQ55250531-B484BA52-1672-48E5-975E-9D5BEAC5A60AQ55258217-AE457898-CE09-4BBA-9D85-63E4F53E3FCFQ55379918-4D72A838-DE5B-4342-ADFF-E69373B07B77Q55456504-C32A0603-E90C-4052-939D-096B14DE5AA5Q55503094-39AD23E2-7D7A-4FEB-97A5-4B050A4C192FQ57114860-65F2E22E-150A-4F75-95AC-85CA1369EE55Q58123798-C6063636-0510-43E5-B0D2-793EFD54ECEAQ58590774-2F71925D-6ED8-4BAD-9476-0B86E46DC9BCQ58705640-86C34F09-AB7B-4DBF-B02C-D621B91352E4
P2860
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@en
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@nl
type
label
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@en
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@nl
prefLabel
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@en
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P1433
P1476
Molecular mechanisms of lipoto ...... alcoholic fatty liver disease.
@en
P2093
Arun J Sanyal
Bubu A Banini
Manoela Mota
Sophie C Cazanave
P2860
P304
P356
10.1016/J.METABOL.2016.02.014
P577
2016-03-03T00:00:00Z